Name | adriamycinol |
---|---|
Synonyms |
14-hydroxydaunomycinone
adriamycinaglycone 8-glycoloyl-7,8,9,10-tetrahydro-6,8,10,11-tetrahydroxy-1-methoxy-5,12-Naphthacenedione doxorubicin aglycone Doxorubicinol Adriamycin-aglycon (1S,3S)-3-[(1S)-1,2-Dihydroxyethyl]-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-tetracenyl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside Epirubicin aglycone doxorubicin hydroxyaglycone 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-[(1S)-1,2-dihydroxyethyl]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)- Epirubicin aglycon Doxorubicinone 13-dihydrodoxorubicin |
Description | Doxorubicinol, a potent inhibitor of the cardiac sarcoplasmic reticulum calcium pump, inhibits systolic myocardial function in isolated heart muscle. Doxorubicinol inhibits tumor cell growth and has cardiotoxicity. |
---|---|
Related Catalog | |
In Vitro | Doxorubicinol 抑制分离的乳头肌的舒张功能(即增加静息压)[1]。 Doxorubicinol 在显著降低舒张功能的浓度下,阿霉素几乎完全消除钙泵活性[1]。 Doxorubicinol 抑制 Ca2+ 刺激的骨骼肌肌浆网的 ATP 酶活性,并消除犬和兔心脏制备物中肌膜的 Na+/K+-ATP 酶活性[1]。 Doxorubicinol 抑制 PANC-1 细胞的增殖,IC50 值为 35.4 μM,PD PaCa 细胞的 IC50 值为 44.5 μM,WD PaCa 细胞的 IC50 值为 49.5 μM[1]。 |
References |
Density | 1.6±0.1 g/cm3 |
---|---|
Boiling Point | 828.7±65.0 °C at 760 mmHg |
Molecular Formula | C27H31NO11 |
Molecular Weight | 545.54 |
Flash Point | 455.0±34.3 °C |
Exact Mass | 545.189697 |
PSA | 209.23000 |
LogP | 2.01 |
Vapour Pressure | 0.0±3.2 mmHg at 25°C |
Index of Refraction | 1.717 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATAMUTATION DATA
|
Precursor 0 | |
---|---|
DownStream 1 | |